March 4, 2015 6:13 PM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Pharmacyclics Inc. (NASDAQ: PCYC) will get acquired by Johnson & Johnson (NYSE: JNJ) according to an unconfirmed report Wednesday by Bloomberg.The report, citing unnamed sources, said Pharmacyclics may fetch up to $18 billion in a sales agreement that could get unveiled Thursday. Pharmacyclics market capitalization as of Wednesday is $16.54 billion.The Sunnyvale, California-based cancer drug maker changed hands in the extended session recently at $236.98, after closing at $230.48. The shares are up more than 40 percent during the past month.Bloomberg reported Feb. 25 that Pharmacyclics was considering a sale and had obtained interest from both Johnson & Johnson as well as Novartis AG (NYSE: NVS).
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.